Paper23560366
Tacrolimus-induced severe cholestasis complicating renal transplantation.
Yadav DK and 6 others. Ren Fail, 2013. Cited by 16 papers, by iCite.
Cite this record
ConductScience Library. Tacrolimus-induced severe cholestasis complicating renal transplantation. Papers, record 23560366. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23560366
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cholestasis, Intrahepatic | Major topic |
| Immunosuppressive Agents | Major topic |
| Kidney Transplantation | Major topic |
| Tacrolimus | Major topic |
| Adult | |
| Humans | |
| Male |
Source PubMed
Cited by9
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 16 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 38409063 | Tacrolimus-induced cholestatic hepatotoxicity after renal transplantation: a case report. | J Med Case Rep | 2024 | https://conductscience.org/library/papers/38409063 | PubMed |
| 36839830 | Sustained Release of Tacrolimus Embedded in a Mixed Thermosensitive Hydrogel for Improving Functional Recovery of Injured Peripheral Nerves in Extremities. | Pharmaceutics | 2023 | https://conductscience.org/library/papers/36839830 | PubMed |
| 36514062 | Protective effect of silymarin on tacrolimus-induced kidney and liver toxicity. | BMC Complement Med Ther | 2022 | https://conductscience.org/library/papers/36514062 | PubMed |
| 34900494 | A Novel Homozygous Mutation in the MYO5B Gene Associated With Normal-Gamma-Glutamyl Transferase Progressive Familial Intrahepatic Cholestasis. | Cureus | 2021 | https://conductscience.org/library/papers/34900494 | PubMed |
| 34150686 | Role of Tacrolimus C/D Ratio in the First Year After Pediatric Liver Transplantation. | Front Pediatr | 2021 | https://conductscience.org/library/papers/34150686 | PubMed |
| 31149309 | A SEVERE CASE OF HYPERGLYCEMIA IN A KIDNEY TRANSPLANT RECIPIENT UNDERGOING INTERFERON-FREE THERAPY FOR CHRONIC HEPATITIS C. | Acta Endocrinol (Buchar) | 2018 | https://conductscience.org/library/papers/31149309 | PubMed |
| 29330784 | Tacrolimus Concentration in Saliva of Kidney Transplant Recipients: Factors Influencing the Relationship with Whole Blood Concentrations. | Clin Pharmacokinet | 2018 | https://conductscience.org/library/papers/29330784 | PubMed |
| 28083020 | Analysis of liver function test abnormalities in kidney transplant recipients: 7 year experience. | Pak J Med Sci | 2016 | https://conductscience.org/library/papers/28083020 | PubMed |
| 26746208 | Protective effect of mycophenolate mofetil against nephrotoxicity and hepatotoxicity induced by tacrolimus in Wistar rats. | J Physiol Biochem | 2016 | https://conductscience.org/library/papers/26746208 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/23560366
GET https://conductscience.org/api/papers/v1/23560366/authors